HCID 17749752, 화합물 → 5-(2-Chlorophenyl)-4-{[3-(2-chlorophenyl)pyrrolidin-1-yl]carbonyl}isoxazole
반응식
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[O:12][N:11]=[CH:10][C:9]=1[C:13]([OH:15])=O.C(O)(=O)C(O)=O.[Cl:22][C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=1[CH:29]1[CH2:33][CH2:32][NH:31][CH2:30]1>>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[O:12][N:11]=[CH:10][C:9]=1[C:13]([N:31]1[CH2:32][CH2:33][CH:29]([C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][C:23]=2[Cl:22])[CH2:30]1)=[O:15]참가 물질
3
실험 절차
The title compound was prepared from 5-(2-chlorophenyl)isoxazole-4-carboxylic acid (11.2 mg, 0.050 mmol) and 3-(2-chlorophenyl)pyrrolidine oxalate (16.3 mg, 0.060 mmol) as described in synthetic method C and thereafter purified by preparative HPLC method B to give a solid (4.0 mg). MS (pos) m/z 387.0 (M+H).
후처리
- custompurified by preparative HPLC method B
출처 및 근거
- ORD 기록
- ord-e103675ef2654f74810d127d07f4ce42
- 출처 데이터셋
- uspto-grants-2010_02
- 특허 번호
- US07666888B2
반응 노트
불러오는 중…